CSIMarket
 
F star Therapeutics Inc.  (FSTX)
Other Ticker:  
 
 


The company disclosed that operating loss in the second quarter of 2022

F Star Therapeutics Inc. reported second quarter of 2022 operating loss of $-16.181 millions

Published 2022-08-13T20:21:38-04:00
Goran Soko / CSIMarket.com Contributer

pills_rapid_release_pills_By_Katy_Warner_from_Orlando_FL_USA_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons The Major Pharmaceutical Preparations industry consultants begin to analyze the second quarter of 2022 results. Today they observe operating loss of $-16.181 millions, from the company, as it hasn't stated any revenue yet, for the own April to June 30 2022 quarter.

Within the latest developing span of the corporation, the markets hope for additional business strategy to come as early as feasible. The markets pay less attention to the recent organization's current efficiency at the Major Pharmaceutical Preparations company.


Seeking to develop a prosperous business strategy, businesses frequently undergo uncommonly bumpy period. Amid this, has been the second quarter of 2022, where the net loss has widen to $-18.994 millions.


F Star Therapeutics Inc. is expected to report next financial results on November 09, 2022.


    Recently Reported Results
Aerial_open_mine_by_Steve_Jurvetson__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Common Novagold Resources Inc

The Metal Mining company published Revenue of $18449 millions, in the fiscal period ending March 31 2022

NG has seen $18449 millions, in Revenue in the fiscal time-frame ending March 31 2022.


Montage_By_Michael_Schmahl_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Construction Spending

U.S. construction spending dropped in the June 2022

Outlays for U.S. construction projects fell after recent increases, as decline in private spending offset an increase in public spending.

closeup_By_Jean-Etienne_Minh-Duy_Poirrier_from_Bruxelles_Belgium_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons Schrodinger Inc.

Despite of the boost in Revenues Profitability not Reached by the Schrodinger Inc. during the most recent fiscal period

the Biotechnology & Pharmaceuticals company announced in the Jun 30 2022 report surge in Revenues by 29.16 % to $38.47 millions from the corresponding reporting period a year before, but it has increased a loss per share at $-0.67 per share.


smartphone-1894723__340 Knightscope Inc.

Critical times for Knightscope Inc. in the financial second quarter of 2022

For the second quarter of 2022 earnings season Knightscope Inc. had turn a round to profits by exhibiting EPS of $0.02 per share compare to $-4.18 a year prior and earnings per share turned positive from $-0.30 per share from the preceding reporting season.

Revenues went down sharply by -69.416 % to $1.04 millions from $3.41 millions in the corresponding reporting season a year prior and sequentially Revenues advanced by 10.381 % from $0.94 millions.


investment-2986344__340 Technology And Telecommunication Acquisition Corpo

For the most recent fiscal period TETE profitability turned positive of $0.02 per share compare to $-4.18 a year ago and from $0.00 per share from the previous reporting season.

Revenues remained unaltered to $0.00 millions from $3.41 millions in the same reporting season a year ago and sequentially Revenues advanced from $0.00 millions.


Loxley_Farm_Market_Produce_By_Infrogmation_of_New_Orleans_[CC-BY-SA-3.0_(http_creativecommons.org_licensesby-sa3.0)]_via_Wikimedia_Commons Consumer Price Index

Consumer Prices returned to Growth in August 2022

U.S. CPI on the rise again after stagnation in the last month, as a decline in energy costs didn't immediately filter through the rest of the economy.

unemployed_lines_pd Employment Report

Economy gains 315,000 jobs in August 2022, but the unemployment rate climbs to 3.7 %

The nonfarm payrolls grew 315,000 in August 2022, as faster hiring puts more money in the hands of consumers, what usually leads to an increase in spending,

turn-on-2932999__340 Producer Price Index

Wholsale prices continued to decline in August 2022

U.S. Producer prices continued to fell in August 2022, due to constant decline in petroleum prices.

business-idea-2988085_960_720.jpg Hubilu Venture Corporation

Hubilu Venture Corporation reported Revenue of $0.393802 millions, in the April to June 30 2022

the Consulting Services company has seen $0.393802 millions, in Revenue in the second quarter of 2022 earnings season.


pills_rapid_release_pills_By_Katy_Warner_from_Orlando_FL_USA_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Advaxis Inc.

For the financial third quarter of 2022 Advaxis Inc. increased a shortfall per share of $-3.83 per share compare to $-0.02 a year prior and advanced shortfall from $-1.90 per share from the prior financial reporting period.

Revenues remained unscathed to $0.00 millions from $0.25 millions in the comparable financial reporting period a year prior and sequentially Revenues advanced from $0.25 millions.


container_ship_container_ship_charge_freighter_cargo_shipping_transport-715194 Unique Logistics International Inc.

An eye-catching deterioration in Revenues at Unique Logistics International Inc. in the fiscal fourth quarter of 2022

For the March to May 31 2022 period Unique Logistics International Inc. reached break-even of $0.00 per share compare to $-0.00 a year prior and from $-0.01 per share from the preceding reporting season.

Revenues faded by -34.943 % to $326.35 millions from $501.64 millions in the similar reporting season a year prior and sequentially Revenue Tumbled by -33.903 % from $493.75 millions.


Model2100sm_By_Goldstein_Group__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Common Quarta Rad Inc.

Very noticeable Contraction in Revenues at the company over the second quarter of 2022 earnings season

For the most recent fiscal period company reached 0 of $0.00 per share compare to $0.00 a year ago and from $0.00 per share from the prior reporting period.

Revenues faded by -32.393 % to $0.24 millions from $0.36 millions in the similar reporting period a year ago and sequentially Revenue Tumbled by -36.143 % from $0.38 millions.


Wells_Fargo_Center_at_Sunset_By_refractor_(Flickr)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Verus International Inc.

For the most recent fiscal period RBIZ reached zero gain of $0.00 per share compare to $-0.02 a year ago and from $-0.01 per share from the preceding financial reporting period.

Revenues remained unscathed to $0.00 millions from $1.85 millions in the similar financial reporting period a year ago and sequentially Revenue Tumbled from $0.00 millions.


architecture-2256489_960_720 Selectis Health Inc.

For the April to June 30 2022 time-frame company bottom-line turned positive of $0.34 per share compare to $-0.03 a year prior and earnings per share more than doubled by 385.71 % from $0.07 per share from the previous reporting period.

Revenues remained unaffected to $-0.00 millions from $6.01 millions in the similar reporting period a year prior and sequentially Revenue Tumbled from $-0.00 millions.




Other FSTX's Earnings Reports

F Star Therapeutics reported first quarter 2022 earnings

F Star Therapeutics reported fourth quarter 2021 earnings

F Star Therapeutics reported third quarter 2021 earnings

       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

KAVL's Profile

Stock Price

KAVL's Financials

Business Description

Fundamentals

Charts & Quotes

KAVL's News

Suppliers

KAVL's Competitors

Customers & Markets

Economic Indicators

KAVL's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071